Bayer will pay up to $600 for the 59.2% stake in engineered-cell therapy developer BlueRock Therapeutics it does now own, following a $225m round in 2016.
SoftBank, Bank Mandiri and Sinar Mas could exit payment software provider Moka in a $100m cash-and-share acquisition by Go-Jek.
Glovo, which counts several corporates as investors, has entered discussions with Uber and Deliveroo over a possible acquisition, while SoftBank could potentially provide equity funding.
Hillrom is paying $130m to snap up Johnson & Johnson-backed respiratory therapy system developer Breathe, which had raised at least $62m in funding.
SurveyMonkey has acquired the Campaign Monitor-owned online enterprise survey provider in a $68m deal that will give equity to Salesforce Ventures.
Hewlett Packard Enterprise reportedly paid less than $50m for the assets of Qualcomm Ventures and CapitalG-backed MapR, which had once been valued at more than $1bn.